$Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: Results of a phase 2 consortium study$

Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: Results of a phase 2 consortium study

10.1016/S1470-2045(10)70203-5

Saved in:

Bibliographic Details
Main Authors:	Bible, K.C., Suman, V.J., Molina, J.R., Smallridge, R.C., Maples, W.J., Menefee, M.E., Rubin, J., Sideras, K., Morris, J.C., McIver, B., Burton, J.K., Webster, K.P., Bieber, C., Traynor, A.M., Flynn, P.J., Goh, B.C., Tang, H., Ivy, S.P., Erlichman, C.
Other Authors:	PHARMACOLOGY
Format:	Article
Published:	2016
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/127090
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items